SCHEMBL7546321

SCHEMBL7546321

C1=C(c2ccccc2)C(c2ccccc2)c2ccccc2O1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 1/20 0.34
LMNA P02545 4/20 0.33
MAPT P10636 4/20 0.33
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
HTT P42858 2/20 0.33
NPSR1 Q6W5P4 1/20 0.33
CFTR P13569 1/20 0.32
GOPC Q9HD26 1/20 0.32
GAA P10253 1/20 0.31
MAPK1 P28482 3/20 0.31
MAOA P21397 1/20 0.31
MAOB P27338 1/20 0.31
TP53 P04637 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31
HTR2B P41595 1/20 0.31
ALDH1A1 P00352 2/20 0.30
TSHR P16473 1/20 0.30
ESR2 Q92731 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8934594 0.77 ESR2 (0.44) CYP2C9MAPTMEN1KMT2ANPSR1
SCHEMBL19454269 0.76 MAOA (0.48) CYP2C9MAOAMAOBATM
SCHEMBL16046136 0.74 MAPT (0.41) LMNAMAPTMEN1KMT2AHTT
SCHEMBL4323808 0.72 MEN1 (0.40) CYP2C9LMNAMAPTMEN1KMT2A
SCHEMBL40368 0.70 CYP2C9 (0.55) CYP2C9LMNAMAPTMEN1KMT2A
SCHEMBL2011512 0.69 MAPT (0.35) CYP2C9LMNAMAPTMEN1KMT2A
SCHEMBL1387828 0.68 CFTR (0.38) CYP2C9LMNAMAPTCFTRGOPC
SCHEMBL4583348 0.67 LMNA (0.46) CYP2C9LMNAMAPTMEN1KMT2A
SCHEMBL29040549 0.67 PTPN1 (0.36) CYP2C9LMNACFTRGOPCGAA
SCHEMBL6241456 0.66 CYP2C9 (0.42) CYP2C9LMNAMAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0873122-B1 USE OF 3,4-DIPHENYL CHROMANS FOR THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PROPHYLAXIS OF PROSTATIC CARCINOMA NOVO NORDISK AS (DK) 2002-06-12 EP disclosed
EP-0873122-A1 USE OF 3,4-DIPHENYL CHROMANS FOR THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PROPHYLAXIS OF PROSTATIC CARCINOMA NOVO NORDISK A/S (DK) 1998-10-28 EP disclosed